Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2021
BANNOCKBURN, Ill. , Aug. 03, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30,
Toggle Summary Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2022
BANNOCKBURN, Ill. , July 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the second quarter ended June 30, 2022
Toggle Summary Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023
BANNOCKBURN, Ill. , July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023
Toggle Summary Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2020
BANNOCKBURN, Ill. , Nov. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30,
Toggle Summary Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2021
BANNOCKBURN, Ill. , Nov. 04, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30,
Toggle Summary Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023
BANNOCKBURN, Ill. , Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30,
Toggle Summary Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2022
BANNOCKBURN, Ill. , Oct. 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the third quarter ended September 30,
Toggle Summary Option Care Health Announces Increased Share Repurchase Authorization
BANNOCKBURN, Ill. , Dec. 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that it anticipates completing the remaining $75 million of
Toggle Summary Option Care Health Announces Issuance of $250 Million in Additional First Lien Term Loan and Concurrent Extinguishment of All Outstanding Second Lien Notes
BANNOCKBURN, Ill. , Jan. 21, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: OPCH)(“Option Care Health” or the Company”), the nation’s largest independent home and alternate site infusion services provider, announced today that it has successfully issued $250 million in additional first
Toggle Summary Option Care Health Announces Offering of $500 Million of Senior Notes and Amendment and Extension of First Lien Term Loan
BANNOCKBURN, Ill. , Oct. 20, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”) announced today that it intends to offer $500 million in aggregate principal amount of senior notes due 2029 (the “Notes”), subject to market and other conditions